Comparative effectiveness of lenalidomide/dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States: An analysis of real-world electronic health records data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative effectiveness of lenalidomide/dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States: An analysis of real-world electronic health records data

Published:2024-06 Issue: Volume:50 Page:101078
ISSN:0147-0272
Container-title:Current Problems in Cancer
language:en
Short-container-title:Current Problems in Cancer

Author:

Ailawadhi Sikander^ORCID,Cheng Mu^ORCID,Cherepanov Dasha,DerSarkissian Maral,Stull Dawn Marie,Hilts Annalise,Chun Justin,Duh Mei Sheng,Sanchez Larysa

Publisher

Elsevier BV

Reference50 articles.

1. Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma;Bruno;Expert Rev Hematol,2020

2. SEER Cancer Statistics Review, 1975–2018,2022

3. Multiple myeloma: patient outcomes in real-world practice;Yong;Br J Haematol,2016

4. Relapsed refractory multiple myeloma: a comprehensive overview;Bazarbachi;Leukemia,2019

5. Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group;Sonneveld;Blood J Am Soc Hematol,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP